Fujita Health University · Faculty of Medical Sciences / Graduate School of Medical Sciences · 教授

Research keywordsPharmacovigilance・adverse event databases・cisplatin-induced nephrotoxicity・immune checkpoint inhibitor toxicities・palliative care pharmacotherapy・COVID-19 Therapeutics・anticholinergic adverse effects・drug safety signal detection・febrile neutropenia risk

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.2026 · JMIR research protocols
• Factors for Discontinuation of Naldemedine Therapy in a Palliative Ward2025 · In Vivo
• A multicenter retrospective study evaluating the effect of proton pump inhibitors on adjuvant tegafur-uracil/leucovorin efficacy for stage II–III colorectal cancer2025 · Scientific Reports
• Incidence of somnolence and dizziness induced by mirogabalin and pregabalin under opioid treatment: a single-center observational study.2025 · Journal of pharmaceutical health care and sciences

• シスプラチン誘発性腎障害に対するシスプラチン代謝関連酵素阻害剤の有効性及び安全性を検証する特定臨床研究2024 · 臨床研究・治験推進研究事業
• 多角的なSARS-CoV-2免疫獲得状況の調査研究2023 · 科学研究費助成事業
• 第三世代RNAワクチン技術を用いた新型コロナウイルスワクチン第I/II相試験2020 · ワクチン開発推進事業

• Official profile